1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics in Oceania Countries, October 2013 (p7)

Pharmaceutical Analysis & Statistics in Oceania Countries, October 2013 (p7)

181-195 of about 200 reports

Purchase Reports From Reputable Market Research Publishers

Therapy Class Overview : Hepatitis C Virus Infection

Therapy Class Overview : Hepatitis C Virus Infection

  • $ 1000
  • Industry report
  • October 2013
  • by MP Advisors

Freedom from injecting Interferon (IFN), treating major HCV genotypes WW and betting on vaccines could bring a sea of change in the treatment of HCV infection in the future. This year the first IFN-free ...

  • Industries : Therapy, Pathology
  • Countries : Asia, Australia, China, Taiwan, World, Vietnam, India, Pakistan, Egypt, Saudi Arabia, Syrian Arab Republic
Healthcare and Pharmaceuticals Report Australia August 2013

Healthcare and Pharmaceuticals Report Australia August 2013

  • $ 190
  • Industry report
  • August 2013
  • by The Economist Intelligence Unit

Disease trends;Healthcare;Healthcare;Healthcare;Pharmaceuticals and biotechnology;Healthcare;Spending and provision NCAIS: 62 SIC: 80

  • Industries : Healthcare
  • Countries : Australia
Go Healthy New Zealand Ltd in Consumer Health (New Zealand)

Go Healthy New Zealand Ltd in Consumer Health (New Zealand)

  • $ 131
  • Company report
  • July 2013
  • by Euromonitor International

Go Healthy New Zealand is interested in providing quality vitamins and dietary supplements to New Zealand consumers. The company also focuses on introducing innovative products that suit consumer needs. ...

  • Industries : OTC, Healthcare
  • Countries : New Zealand
Mylan New Zealand Ltd in Consumer Health (New Zealand)

Mylan New Zealand Ltd in Consumer Health (New Zealand)

  • $ 131
  • Company report
  • July 2013
  • by Euromonitor International

Over the forecast period Mylan New Zealand Ltd will focus on its core business of manufacturing and distributing pharmaceutical prescription and OTC consumer health products. Euromonitor International ...

  • Industries : OTC, Pharmaceutical
  • Countries : New Zealand
Douglas Pharmaceuticals Ltd in Consumer Health (New Zealand)

Douglas Pharmaceuticals Ltd in Consumer Health (New Zealand)

  • $ 131
  • Company report
  • July 2013
  • by Euromonitor International

By focusing on low-volume high-value products, Douglas Pharmaceuticals continues to attract consumers and expand its operations. Douglas Pharmaceuticals focuses on generic as well as difficult to manufacture ...

  • Industries : Pharmaceutical, OTC
  • Countries : New Zealand
Ear Care in New Zealand

Ear Care in New Zealand

  • $ 912
  • Industry report
  • July 2013
  • by Euromonitor International

Ear care value sales increased by 2% in 2012, which is lower than the 2011 growth of 33%. This is also compared with the current value review period CAGR of 8%. Higher growth in 2011 and over the review ...

  • Industries : OTC
  • Countries : New Zealand
OTC Triptans in New Zealand

OTC Triptans in New Zealand

  • $ 912
  • Industry report
  • July 2013
  • by Euromonitor International

During 2012 there were only two OTC triptan products available in New Zealand, Sumagran Active (Mylan New Zealand) and Zomig (AstraZeneca). Several other prescription products were available, such as Maxalt ...

  • Industries : OTC
  • Countries : New Zealand
Emergency Contraception in New Zealand

Emergency Contraception in New Zealand

  • $ 912
  • Industry report
  • July 2013
  • by Euromonitor International

Emergency contraception continued to be an acceptable medical method of preventing pregnancy within New Zealand during 2012. While abortion services are provided for free within New Zealand for permanent ...

  • Industries : OTC
  • Countries : New Zealand
Australian Pharmaceutical Industries Ltd in Retailing (Australia)

Australian Pharmaceutical Industries Ltd in Retailing (Australia)

  • $ 131
  • Company report
  • July 2013
  • by Euromonitor International

Australian Pharmaceutical Industries Ltd is planning for rapid expansion in Australia, with the aim of opening at least 400 Priceline stores by 2014. This target amounts to an expansion of up to 50% from ...

  • Industries : Pharmaceutical
  • Countries : Australia
Pharmacybrands Ltd in Retailing (New Zealand)

Pharmacybrands Ltd in Retailing (New Zealand)

  • $ 131
  • Company report
  • May 2013
  • by Euromonitor International

Pharmacybrands is expected to continue expanding its network of chemists/pharmacies across New Zealand through its five fascias; Amcal, Care Chemist, Radius Pharmacy, Life Pharmacy and Unichem. The company ...

  • Industries : Pharmacies and Drug Stores
  • Countries : New Zealand
Cottons Pty Ltd in Tissue and Hygiene (Australia)

Cottons Pty Ltd in Tissue and Hygiene (Australia)

  • $ 131
  • Company report
  • May 2013
  • by Euromonitor International

Cottons differentiates itself from its competitors through its use of natural ingredients. This has been, and will remain, the company’s key point of difference amongst the synthetic products more typical ...

  • Industries : Agricultural Products
  • Countries : Australia
De Jour Sanitary Products in Tissue and Hygiene (Australia)

De Jour Sanitary Products in Tissue and Hygiene (Australia)

  • $ 131
  • Company report
  • May 2013
  • by Euromonitor International

De Jour Sanitary Products is in a precarious situation. As a fading player that primarily competes in tampons, a category that has delivered half a decade of decline, it will over the forecast period be ...

  • Industries : OTC
  • Countries : Australia
iNova Pharmaceuticals (Australia) Pty Ltd in Consumer Health (Australia)

iNova Pharmaceuticals (Australia) Pty Ltd in Consumer Health (Australia)

  • $ 131
  • Company report
  • March 2013
  • by Euromonitor International

iNova Pharmaceuticals (Australia) Pty Ltd is focusing on acquiring products and distribution rights to continue its expansion in Australia and in the export markets of New Zealand, the Asia-Pacific region ...

  • Industries : Pharmaceutical
  • Countries : Australia
Emergency Contraception in Australia

Emergency Contraception in Australia

  • $ 912
  • Industry report
  • March 2013
  • by Euromonitor International

Emergency contraception is available in Australia. The product is Schedule 3, which means it can only be sold from behind the counter, involving interaction with a pharmacist. The emergency contraceptive ...

  • Industries : OTC
  • Countries : Australia
Ear Care in Australia

Ear Care in Australia

  • $ 912
  • Industry report
  • March 2013
  • by Euromonitor International

Acute otitis media is an ear infection where ear care products are used to relieve pain, while the growing popularity of swimming and the subsequent incidence of swimmer’s ear represent a key drive ...

  • Industries : OTC
  • Countries : Australia

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.